← Leaderboards
Leslie S Johnson
Macrogenics, Inc.
$4,864,237
Attributed
$4,864,237
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2010–13$2M$1.5M$1M$500K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$4,864,237 · 3
By mechanism
R01$4,664,237 · 1
R43$200,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Receptor Binding”
- Barton F Haynes · Duke University$185,264,749
- James C. Paulson · Scripps Research Institute$95,448,398
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$46,554,883
- Anthony O Caggiano · Cognition Therapeutics, Inc.$43,047,809
- Norbert E Kaminski · Michigan State University$39,404,844
- Leonidas A Stamatatos · Fred Hutchinson Cancer Center$39,383,866
Research focus
Receptor BindingCross ReactivityAreaComplementCollaborationsAedes (Genus)AffinityClinical ResearchAntibody EngineeringCommunicable DiseasesAntibodiesBinding (Molecular Function)Binding SitesAntigen BindingCollectionCategoriesAntibody-Dependent EnhancementClinicCell BankCell LineCellular TargetingCharacteristicsBaseCross Immunity
Grant awards (6)
A Pan-Dengue Virus Immunotherapeutic for Prevention and Treatment$1,185,525
R01 · FY2013 · AI · contact PI
A Pan-Dengue Virus Immunotherapeutic for Prevention and Treatment$1,262,889
R01 · FY2012 · AI · contact PI
A Pan-Dengue Virus Immunotherapeutic for Prevention and Treatment$1,197,162
R01 · FY2011 · AI · contact PI
A Pan-Dengue Virus Immunotherapeutic for Prevention and Treatment$1,018,661
R01 · FY2010 · AI · contact PI
FcRlll Blockade as a Treatment for Autoimmune Disease$100,000
R43 · FY2004 · AI
Development of Soluble FcR-Ig Fusion Proteins$100,000
R43 · FY2004 · AI